Zimmer Partners, LP Biogen Inc. Transaction History

Zimmer Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $2.81 Million - $3.55 Million	13,250 Added 11.35%	129,950 $28 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $21.6 Million - $26 Million	97,100 Added 495.41%	116,700 $30.2 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $5.39 Million - $6.23 Million	19,600 New	19,600 $5.58 Million

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Zimmer Partners, LP with notifications on news.